Nephrotoxicity of lopamidol in pediatric, adolescent, and young adult patients who have undergone allogeneic bone marrow transplantation

Radiology

Volumn 226, Issue 2, 2003, Pages 399-404

  Haight, Ann E ^a   Kaste, Sue C ^a,b   Goloubeva, Olga G ^a   Xiong, Xiaoping P ^a   Bowman, Laura C ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Abdomen, CT; Bone marrow, transplantation; Contrast media, effects; Contrast media, toxicity; Kidney, effects of drugs on; Thorax, CT

Indexed keywords

ANTIINFECTIVE AGENT; CREATININE; FOSCARNET; IOPAMIDOL; NITROGEN; UREA; CONTRAST MEDIUM; IMMUNOSUPPRESSIVE AGENT;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHILD; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INFANT; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEPHROTOXICITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UREA NITROGEN BLOOD LEVEL; ADOLESCENT; BLOOD; BONE MARROW TRANSPLANTATION; CHEMICALLY INDUCED DISORDER; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; KIDNEY; KIDNEY DISEASE; PRESCHOOL CHILD;

ADOLESCENT; ADULT; BLOOD UREA NITROGEN; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CONTRAST MEDIA; CREATININE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; IOPAMIDOL; KIDNEY; KIDNEY DISEASES; MALE; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037295278     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2262011471     Document Type: Article

References (39)

1. Mathew P, Bozeman P, Krance RA, Brenner MK, Heslop HE. Brochiolitis obliterans organizing pneumonia (BOOP) in children after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 13:221-223.
2. Wingard JR. Fungal infections after bone marrow transplant. Biol Blood Marrow Transplant 1999; 5:55-68.
3. Archibald S, Park J, Geyer R, et al. Computed tomography in the evaluation of febrile neutropenic pediatric oncology patients. Pediatric Infect Dis 2001; 20:5-10.
4. Benya EC, Goldman S. Bone marrow transplantation in children: imaging assessment of complications. Pediatr Clin North Am 1997; 44:741-761.
5. Evans JR, Shankel SW, Cutler RE. Low osmolar contrast agents and nephrotoxicity (letter). Ann Intern Med 1987; 107: 116.
6. Kinnison ML, Powe NR, Steinberg EP. Results of randomized controlled trials of low- versus high-osmolality contrast media. Radiology 1989; 170:381-389.
7. Schwab SJ, Hlatky MA, Pieper KS, et al. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med 1989; 320:149-153.
8. Venables WN, Ripley BD. Linear statistical models. In: Venables WN, Ripley BD. Modern applied statistics with S-PLUS. 3rd ed. New York, NY: Springer, 1997; 149-208.
9. Chambers JM. Linear models. In: Chambers JM, Hastie TJ, eds. Statistical models in S. Pacific Grove, Calif: Wadsworth & Brooks, 1993; 96-138.
10. Milliken GA, Wolfinger RD, Littell RC, Stroup WW. Random effects models. In: Milliken GA, Wolfinger RD, Littell RC, Stroup WW, eds. SAS system for mixed models. Cary, NC: SAS Institute, 1997; 135-169.
11. Hongeng S, Krance RA, Bowman LC, et al. Outcomes of transplantation with matchedsibling and unrelated-donor bone marrow in children with leukaemia. Lancet 1997; 350:767-771.
12. Handgretinger R, Schumm M, Lang P, et al. Transplantation of megadoses of purified haploidentical stem cells. Ann N Y Acad Sci 1999; 872:351-361.
13. Slavin S, Nagler A, Napastek E. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91:756-763.
14. Bortin MM, Horowitz MM, Rimm AA. Increasing utilization of allogeneic bone marrow transplantation: results of the 1988-1990 survey. Ann Intern Med 1992; 166:505-512.
15. Henslee-Downey PJ, Abhyankar SH, Parrish RS, et al. Use of partially mismatched related donors extends access to allogeneic marrow transplant. Blood 1997; 89: 3864-3872.
16. Verma UN, Mazumder A. Immune reconstitution following bone marrow transplantation. Cancer Immunol Immunother 1993; 37:351-360.
17. Van Burik J, Weisdorf DJ. Infections in recipients of blood and marrow transplantation. Hematol Oncol Clin North Am 1999; 13:1065-1089.
18. O'Donnell MR, Schmidt GM, Tegtmeirer BR, et al. Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients. J Clin Oncol 1994; 12:827-834.
19. Hagensee JE, Bauwens JE, Kjos B. Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992. Clin Infect Dis 1994; 19:402-408.
20. De Medeiros DR, Dantas da Cunha A, Pasquini R, Arns da Cunha C. Primary renal aspergillosis: extremely uncommon presentation in patients treated with bone marrow transplantation. Bone Marrow Transplant 1999; 24:113-114.
21. Drakos PE, Nagler A, Or R, et al. Invasive fungal sinusitis in patients undergoing bone marrow transplant. Bone Marrow Transplant 1993; 12:203-208.
22. Lansford BK, Bower CM, Seibert RW. Invasive fungal sinusitis in the immunocompromised pediatric patient. Ear Nose Throat J 1995; 74:566-573.
23. Walsh TJ, Hiemenz JW, Anaissie E. Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients. Infect Dis Clin North Am 1996; 10:365-400.
24. Goodrich JM, Reed EC, Mori M, et al. Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation. J Infect Dis 1991; 164:731-740.
25. Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood 1997; 90:999-1008.
26. Meyers JD. Fungal infections in bone marrow transplant patients. Semin Oncol 1990; 17(suppl):10.
27. Wolff SN, Fay J, Stevens D, et al. Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group. Bone Marrow Transplant 2000; 25:853-859.
28. Chanock SJ, Walsh TJ. Evolving concepts of prevention and treatment of invasive fungal infections in pediatric bone marrow transplant recipients. Bone Marrow Transplant 1996; 18(suppl 3):S15-S20.
29. Wingard JR, White MH, Anaissie E, et al. A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. Clin Infect Dis 2000; 31:115-163.
30. Dawson P. The physiology and toxicology of low osmolality contrast media. Diagn Imaging Suppl 1987; 9:3-8.
31. Porter GA. Effects of contrast agents on renal function. Invest Radiol 1993; 28 (suppl 5):S1-S5.
32. Lasser EC. New perspectives on contrast media toxicity. In: Lang EK. Current perspectives on contrast media: clinical safety and economic principles for selection of an agent. Louisiana State University School of Medicine, New Orleans, November 3, 1990; 5-6.
33. Berlin L. Ionic versus nonionic contrast media. AJR Am J Roentgenol 1996; 1095-1097.
34. The Committee on Drugs and Contrast Media of the American College of Radiology. Manual on contrast media. 4th ed. Reston, Va: American College of Radiology, 1998.
35. Heussel CP, Kauczor HU, Heussel G, Fischer B, Mildenberger P, Thelen M. Early detection of pneumonia in febrile neutropenic patients: use of thin-section CT. AJR Am J Roentgenol 1997; 169:1347-1353.
36. Posniak HV, Olson MC. Correlative imaging of abdominal infection. In: Henkin RE, Boles MA, Dillehay GL, et al, eds. Nuclear medicine. Vol 2. St Louis, Mo: Mosby, 1996; 1662-1685.
37. Guinan EC, Tarbell NJ, Niemeyer CM, et al. Intravascular hemolysis and renal insufficiency after bone marrow transplantation. Blood 1988; 72:451-455.
38. Van Why SK, Friedman AL, Wei LJ, Hong R. Renal insufficiency after bone marrow transplantation in children. Bone Marrow Transplant 1991; 7:383-388.
39. Kist-van Holthe JE, van Zwet JML, Brand R, et al. Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT. Bone Marrow Transplant 1998; 22:559-564.